Skip to content

Addressing Origins of the Opioid Epidemic by Improving Prescribing for Opioid-Naive Patients

Addressing Origins of the Opioid Epidemic by Improving Prescribing for Opioid-Naive Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03377855
Enrollment
948
Registered
2017-12-19
Start date
2018-02-01
Completion date
2019-12-31
Last updated
2020-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Opioid Abuse, Opioid-Related Disorders, Opioid Use, Prescription Drug Abuse and Dependency

Brief summary

Risk of long-term opioid dependence increases with initial opioid dose/duration, but despite recent Centers for Disease Control and Prevention (CDC)-endorsed minimum doses for initial opioid prescription, primary care providers are likely to overprescribe. In this quality improvement project, primary care departments at Weill Cornell and the Institute for Family Health (federally qualified health center in New York City) will implement an unobtrusive nudge in their electronic prescribing software to promote the CDC-endorsed low doses for all opioids. In the evaluation, we will employ a quasi-experimental design with rigorous interrupted time series analysis methods to assess the effect of the nudge on prescribing rates. The analysis will be performed at the provider level, with deidentified physician data and a limited data set (fully deidentified except for date of prescription) of patient-level data.

Detailed description

The two participating institutions, WCMC (Weill Cornell Medical College) and IFH (Institute for Family Health), intend to redesign the e-prescribing interface to create a minor nudge to encourage prescribers to prescribe the minimum dose set by the 2016 CDC guideline for opioid-naive patients in 2018. The change to the e-prescribing system is that after a prescriber chooses the drug they wish to prescribe, the minimum recommended dosage from the CDC guidelines will be displayed. The prescriber can choose to change the dosage by overwriting in the field box. The changes to the prescriber system will be implemented at two Weill Cornell clinical organizations: Weill Cornell Internal Medicine Associates (WCIMA) and Weill Cornell Medical Associates (CMA), and at all locations at our collaborating institution IFH (Institute for Family Health). Weill Cornell and IFH will provide data for the analysis, which will be conducted by the co-investigators on this protocol. The project will assess data pre- and post- implementation to study prescribing patterns.

Interventions

OTHERDefault Prescribing Change

In the e-prescribing system, the default opioid dosage/duration is changed to the minimum recommended dosage from the CDC guidelines for short acting opioids.

Sponsors

New York State Health Foundation
CollaboratorUNKNOWN
The Institute for Family Health
CollaboratorOTHER
Weill Medical College of Cornell University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Intervention model description

This is a interrupted time series study model with one study group.

Eligibility

Sex/Gender
ALL
Age
18 Years to 89 Years
Healthy volunteers
Yes

Inclusion criteria

* Prescriber - practices internal medicine at WCMC OR family practice at IFH and has prescribed opioids since 11/1/2015

Exclusion criteria

* Prescriber - has not written any opioid prescriptions during the study period

Design outcomes

Primary

MeasureTime frameDescription
Change in the proportion of opioid prescriptions for opioid-naïve patients that comply with CDC recommendations before and after the interventionTwo years prior to and six months after implementationChange in the proportion of opioid prescriptions for opioid-naïve patients that comply with CDC recommendations before and after the intervention

Secondary

MeasureTime frameDescription
Change in the average days of supply of opioids for opioid naive patientsTwo years prior to and six months after implementationChange in the average days of supply of opioids for opioid naive patients

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026